NCT03714191View on ClinicalTrials.gov

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

CompletedOBSERVATIONAL
Enrollment

54,417

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

May 24, 2019

Study Completion Date

February 29, 2020

Conditions
Tobacco Use Cessation
Interventions
OTHER

Patient Outcomes

The intervention includes different versions of the BPA design and message.

OTHER

Billing documentation

The intervention includes different versions of the BPA design and message.

OTHER

Regulatory

The intervention includes different versions of the BPA design and message.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03714191 - Optimizing the Tobacco Cessation Clinical Decision Support Tool. | Biotech Hunter | Biotech Hunter